Sensorimotor Imaging for Brain-Computer Interfaces

NCT04723823 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-08-30

Study results available
· View outcomes & findings →

Summary

The investigators will use fMRI to map movement activity in motor and somatosensory cortex using enriched imagery in people with chronic tetraplegia. The investigators expect that somatotopic organization of movement activity will be preserved in people with upper limb impairments, which can be quantified using the strength, area, and location of sensorimotor activity. Accurate mapping of the motor and somatosensory cortices using covert stimuli will help guide brain-computer interface (BCI) electrode design and placement. Moreover, these advanced mapping procedures will provide new insights into the functional interactions between sensory and motor areas of the brain after injury or disease.

Conditions

  • Functional Neuroimaging

Interventions

OTHER

Motor or sensory imagery with fMRI

Brain activity will be measured using fMRI while participants imagine different movements or sensations in order to assess the organization of sensorimotor cortical activity after injury

Sponsors & Collaborators

  • University of Pittsburgh Medical Center

    collaborator OTHER
  • Carnegie Mellon University

    collaborator OTHER
  • Synchron Medical, Inc.

    collaborator INDUSTRY
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Jennifer L Collinger, PhD · University of Pittsburgh

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-08
Primary Completion
2024-05-21
Completion
2024-05-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04723823 on ClinicalTrials.gov